| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharma/NIH) | Year complete | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| Clinical Risk Factors for Retinopathy of Prematurity Reactivation after Intravitreal Anti-Vascular Endothelial Growth Factor Injection |
114 (223 eyes) |
Chang Gung Memorial Hospital Linkou (Taiwan) |
Retrospective analysis; time span was 2017-2022. |
Lee CC, Chiang MC, Chu SM, Wu WC, Ho MM, Lien R, Clinical risk factors for retinopathy of prematurity reactivation after intravitreal anti-vascular endothelial growth factor injection, J Pediatr. Published online January 11, 2024. doi.org/10.1016/j.jpeds.2024.113913 |